# Impact of the Use of Zinc in the Prevention of Oral Mucositis in Pediatric Patients With Lymphoblastic Acute Leukemia.

> **NCT04321850** · NA · TERMINATED · sponsor: **National Institute of Pediatrics, Mexico** · enrollment: 21 (actual)

## Conditions studied

- Oral Mucositis

## Interventions

- **DRUG:** Zinc Sulfate 50 Mg Tab
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04321850
- **Lead sponsor:** National Institute of Pediatrics, Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-06-10
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-07-30
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Health restrictions due to the COVID-19 pandemic
- **Last updated:** 2020-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04321850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04321850, "Impact of the Use of Zinc in the Prevention of Oral Mucositis in Pediatric Patients With Lymphoblastic Acute Leukemia.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04321850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*